109737-05-5 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 2-(2-oxoindolin-5-yl)acetate is utilized as a key intermediate in the synthesis of pharmaceuticals due to its capacity to contribute to the development of bioactive molecules. Its unique structure allows for the creation of compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, methyl 2-(2-oxoindolin-5-yl)acetate serves as a building block for the production of agrochemicals, playing a crucial role in the synthesis of compounds designed to protect crops and enhance agricultural productivity.
Used in Organic Synthesis:
Methyl 2-(2-oxoindolin-5-yl)acetate is employed as a versatile building block in organic synthesis for the production of fine chemicals. Its structural attributes make it suitable for the creation of specialty chemicals used across various industries.
Used in Drug Discovery:
As a valuable intermediate in drug discovery, methyl 2-(2-oxoindolin-5-yl)acetate is instrumental in the research and development of new pharmaceutical agents. Its unique structural features facilitate the exploration of novel molecular entities with potential medicinal properties.
Check Digit Verification of cas no
The CAS Registry Mumber 109737-05-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,7,3 and 7 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 109737-05:
(8*1)+(7*0)+(6*9)+(5*7)+(4*3)+(3*7)+(2*0)+(1*5)=135
135 % 10 = 5
So 109737-05-5 is a valid CAS Registry Number.
109737-05-5Relevant articles and documents
SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS
-
, (2014/11/11)
The invention relates to novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.
